Actuate Therapeutics Inc (NASDAQ:ACTU) Has Risen By -25.63 Percent Over The Past 30 Days: Will It Continue?

In recent trading session, Actuate Therapeutics Inc (NASDAQ:ACTU) saw 0.52 million shares changing hands at last check today with its beta currently measuring 0. Company’s recent per share price level of $6.22 trading at -$0.01 or -0.08% at last check today assigns it a market valuation of $122.13M. That most recent trading price of ACTU’s stock is at a discount of -92.77% from its 52-week high price of $11.99 and is indicating a premium of 11.58% from its 52-week low price of $5.50. Taking a look at company’s average trading volume for last 10-days demonstrates a volume of 0.11 million shares which gives us an average trading volume of 96.06K if we extend that period to 3-months.

Actuate Therapeutics Inc (NASDAQ:ACTU) trade information

Upright in the red during last session for losing -0.08%, in the last five days ACTU remained trading in the green while hitting it’s week-highest on Thursday, 07/17/25 when the stock touched $6.22 price level, adding 14.44% to its value on the day. Actuate Therapeutics Inc (NASDAQ:ACTU) showed a performance of -25.63% in past 30-days. Number of shares sold short was 0.24 million shares which calculate 3.74 days to cover the short interests.

Wall Street analysts have assigned a consensus price target of 21 to the stock, which implies a rise of 70.38% to its recent value today. Analysts have been projecting 21 as a low price target for the stock while placing it at a high target of 21. It follows that stock’s current price would drop -237.62% in reaching the projected high whereas dropping to the targeted low would mean a loss of -237.62% for stock’s current value.

In 2025, company’s earnings growth rate is likely to be around 66.26% while estimates for its earnings growth in next 5 years are of 12.89%.

Actuate Therapeutics Inc (NASDAQ:ACTU)’s Major holders

Insiders are in possession of 18.94% of company’s total shares while institution are holding 53.53 percent of that, with stock having share float percentage of 66.04%. Investors also watch the number of corporate investors in a company very closely, which is 53.53% institutions for Actuate Therapeutics Inc that are currently holding shares of the company.

On the other hand, Fidelity Concord Street Trust-Fidelity Extended Market Index Fund and Northern Funds-SMALL CAP CORE FUND are the top two Mutual Funds which own company’s shares. As of May 31, 2025 , the former fund manager was holding 16.71 shares of worth $0.1 million or 0.09% of the total outstanding shares. The later fund manager was in possession of 15.8 shares on Mar 31, 2025 , making its stake of worth around $96531.0 in the company or a holder of 0.08% of company’s stock.

Marketing Sentinel
Privacy Overview

This website uses cookies so that we can provide you with the best user experience possible. Cookie information is stored in your browser and performs functions such as recognising you when you return to our website and helping our team to understand which sections of the website you find most interesting and useful.